Abstract
Apolipoprotein (apo-) E is a 299-amino acid, 34-kDa protein that is synthesized and secreted by hepatocytes, macrophages, and astrocytes. It is a component of both plasma and cerebrospinal fluid lipoproteins (Borghini et al, 1995; Mahley, 1988; Pitas, 1997; Pitas et al., 1987). As a component of lipoproteins, apo-E is a ligand for several members of the low density lipoprotein (LDL) receptor gene family, including the LDL receptor itself and the LDL receptor-related protein (LRP) (Krieger and Herz, 1994; Mahley, 1988; Pitas et al., 1979). Apo-E occurs in three common forms that are products of different alleles at the same gene locus (Zannis and Breslow, 1981). The proteins apo-E2, apo-E3, and apo-E4 differ by single amino acid changes at amino acids 112 and 158 (Mahley, 1988). Apo-E2 has cysteine at both positions, apo-E4 has arginine at both positions, and apo-E3 has cysteine at position 112 and arginine at 158 (Mahley, 1988; Weisgraber, 1994). These amino acid substitutions have a profound impact on the metabolic properties of the proteins and their association with disease. Of particular interest is the observation that the apo-E4 allele is overrepresented in subjects with late-onset Alzheimer’s disease (AD) and furthermore that subjects who carry the apo-E4 allele develop AD at an earlier age than those with the apo-E3 allele (Corder et al., 1993; Mayeux et al., 1993; Poirier et al., 1993; Saunders et al., 1993). Apo-E4 is therefore a major risk factor for the development of late-onset AD.
This research was funded in part by NIA Grant AG13619 and NHLBI Program Project Grant HL41633 from the National Institutes of Health. Additional funding was obtained from a Cambridge Neuroscience/Gladstone collaborative research agreement.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bellosta, S., Nathan, B. P., Orth, M., Dong, L.-M., Mahley, R. W., and Pitas, R. E. (1995). Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J. Biol. Chem. 270, 27063–27071.
Bernfield, M., Kokenyesi, R., Kato, M., Hinkes, M. T., Spring, J., Gallo, R. L., and Lose, E. J. (1992). Biology of the syndecans: A family of transmembrane heparan sulfate proteoglycans. Annu. Rev. Cell Biol. 8, 365–393.
Borghini, I., Barja, F., Pometta, D., and James, R. W. (1995). Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid. Biochim. Biophys. Acta 1255, 192–200.
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., and Pericak-Vance, M. A. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261, 921–923.
Han, S.-H., Einstein, G., Weisgraber, K. H., Strittmatter, W. J., Saunders, A. M., Pericak-Vance, M., Roses, A. D., and Schmechel, D. E. (1994). Apolipoprotein E is localized to the cytoplasm of human cortical neurons: A light and electron microscopic study. J. Neuropathol. Exp. Neurol. 53, 535–544.
Han, S.-H., Hulette, C., Saunders, A. M., Einstein, G., Pericak-Vance, M., Strittmatter, W. J., Roses, A. D., and Schmechel, D. E. (1994). Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer’s disease and in age-matched controls. Exp. Neurol. 128, 13–26.
Holtzman, D. M., Pitas, R. E., Kilbridge, J., Nathan, B., Mahley, R. W., Bu, G., and Schwartz, A. L. (1995). Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc. Natl. Acad. Sci. USA 92, 9480–9484.
Huang, D. Y., Goedert, M., Jakes, R., Weisgraber, K. H., Garner, C. C., Saunders, A. M., Pericak-Vance, M. A., Schmechel, D. E., Roses, A. D., and Strittmatter, W. J. (1994). Isoform-specific interactions of apolipoprotein E with the microtubule-associated protein MAP2c: Implications for Alzheimer’s disease. Neurosci. Lett. 182, 55–58.
Huang, D. Y., Weisgraber, K. H., Goedert, M., Saunders, A. M., Roses, A. D., and Strittmatter, W. J. (1995). ApoE3 binding to tau tandem repeat I is abolished by tau serine262 phosphorylation. Neurosci. Lett. 192, 209–212.
Ji, Z.-S., Mahley, R. W, Supekova, L., and Pitas, R. E. (1997). Differential accumulation of apolipoproteins E3 and E4 by cells is mediated by cell-surface heparan sulfate proteoglycans. Abstract submitted for the 27th Annual Meeting of the Society for Neuroscience, to be held in New Orleans, October 25–30, 1997
Kowal, R. C., Herz, J., Weisgraber, K. H., Mahley, R. W., Brown, M. S., and Goldstein, J. L. (1990). Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J. Biol. Chem. 265, 10771–10779.
Krieger, M. and Herz, J. (1994). Structures and functions of multiligand lipoprotein receptors: Macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 63, 601–637.
Lovestone, S., Anderton, B. H., Hartley, K., Jensen, T. G., and Jorgensen, A. L. (1996). The intracellular fate of apolipoprotein E is tau dependent and apoe allele-specific. Neuroreport 7, 1005–1008.
Mahley, R. W. (1988). Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240, 622–630.
Mayeux, R., Stern, Y, Ottman, R., Tatemichi, T. K., Tang, M.-X., Maestre, G., Ngai, C., Tycko, B., and Ginsberg, H. (1993). The apolipoprotein µ4 allele in patients with Alzheimer’s disease. Ann. Neurol. 34, 752–754.
Nathan, B. P., Bellosta, S., Sanan, D. A., Weisgraber, K. H., Mahley, R. W, and Pitas, R. E. (1994). Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264, 850–852.
Nathan, B. P., Chang, K.-C, Bellosta, S., Brisch, E., Ge, N., Mahley, R. W, and Pitas, R. E. (1995). The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J. Biol. Chem. 270, 19791–19799.
Pitas, R. E. (1997). Cerebrospinal fluid lipoproteins, lipoprotein receptors, and neurite outgrowth. Nutr. Metab. Cardiovasc. Dis. In press.
Pitas, R. E., Boyles, J. K., Lee, S. H., Hui, D., and Weisgraber, K. H. (1987). Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J. Biol. Chem. 262, 14352–14360.
Pitas, R. E., Innerarity, T. L., Arnold, K. S., and Mahley, R. W. (1979). Rate and equilibrium constants for binding of apo-E HDLC (a cholesterol-induced lipoprotein) and low density lipoproteins to human fibroblasts: Evidence for multiple receptor binding of apo-E HDLC. Proc. Natl. Acad. Sci. USA 76, 2311–2315.
Poirier, J., Davignon, J., Bouthiliier, D., Kogan, S., Bertrand, P., and Gauthier, S. (1993). Apolipoprotein E polymorphism and Alzheimer’s disease. Lancet 342, 697–699.
Roses, A. D. (1994). Apolipoprotein E affects the rate of Alzheimer disease expression: β-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J. Neuropathol. Exp. Neurol. 55, 429–437.
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., Hulette, C., Crain, B., Goldgaber, D., and Roses, A. D. (1993). Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer’s disease. Neurology 43, 1467–1472.
Strittmatter, W. J., Saunders, A. M., Goedert, M., Weisgraber, K. H., Dong, L.-M., Jakes, R., Huang, D. Y, Pericak-Vance, M., Schmechel, D., and Roses, A. D. (1994). Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: Implications for Alzheimer disease. Proc. Natl. Acad. Sci. USA 91, 11183–11186.
Weisgraber, K. H. (1994). Apolipoprotein E: Structure-function relationships. Adv. Protein Chem. 45, 249–302.
Yanagishita, M. (1992). Glycosylphosphatidylinositol-anchored and core protein-intercalated heparan sulfate pro-teoglycans in rat ovarian granulosa cells have distinct secretory, endocytotic, and intracellular degradative pathways. J. Biol. Chem. 267, 9505–4511.
Zannis, V. I. and Breslow, J. L. (1981). Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification. Biochemistry 20, 1033–1041.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pitas, R.E., Ji, ZS., Supekova, L., Mahley, R.W. (1998). Divergent Metabolism of Apolipoproteins E3 and E4 by Cells. In: Fisher, A., Hanin, I., Yoshida, M. (eds) Progress in Alzheimer’s and Parkinson’s Diseases. Advances in Behavioral Biology, vol 49. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5337-3_4
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5337-3_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7435-0
Online ISBN: 978-1-4615-5337-3
eBook Packages: Springer Book Archive